Zura Bio Limited Warrants
ZURAW
ZURAW was delisted on the 27th of August, 2024.
21 hedge funds and large institutions have $2.37M invested in Zura Bio Limited Warrants in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, 1 reducing their positions, and 3 closing their positions.
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
17% more funds holding
Funds holding: 18 → 21 (+3)
24% less capital invested
Capital invested by funds: $3.1M → $2.37M (-$730K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$135K |
| 2 |
Capstone Investment Advisors
New York
|
+$20.8K |
| 3 |
CCM
Context Capital Management
Lajolla,
California
|
+$10.5K |
| 4 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$4.76K |
| 5 |
AA
Ancora Advisors
Cleveland,
Ohio
|
+$1.04K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$286K |
| 2 |
BGIM
Boussard & Gavaudan Investment Management
London,
United Kingdom
|
-$96K |
| 3 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$5K |
| 4 |
BCM
Basso Capital Management
Stamford,
Connecticut
|
-$12 |
ZURAW Hedge Fund Activity: Q1 2022 in Review
21 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Zura Bio Limited Warrants (ZURAW) for Q1 2022, worth a combined $2.37M — down 24% from $3.1M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new ZURAW positions and 3 closed out — a net gain of 3 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Shaolin Capital Management, opening a new position worth an estimated $135K. The largest seller was Mangrove Partners, exiting entirely with an estimated $286K sold.
- 21 institutional investors held Zura Bio Limited Warrants (ZURAW) as of Q1 2022, up from 18 in Q4 2021.
- Funds reported $2.37M of Zura Bio Limited Warrants stock for Q1 2022, down 24% quarter-over-quarter.
- 6 funds opened new Zura Bio Limited Warrants positions in Q1 2022 and 3 closed out, a net change of +3 holders.
- The largest Zura Bio Limited Warrants buyer in Q1 2022 was Shaolin Capital Management, an estimated $135K added.
- The largest Zura Bio Limited Warrants seller in Q1 2022 was Mangrove Partners, an estimated $286K sold.
Based on aggregated 13F filings for Q1 2022.